ERIS Lifesciences Limited has appointed Murari Ranganathan as the President of Cardiometabolic Business. Based out of the company’s Mumbai office, Ranganathan will oversee Eris’ Anti-Diabetes and Cardiology businesses, strengthening the company’s footprint in the cardiometabolic space.
Before joining Eris, Ranganathan served as the Commercial Director at Abbott India, where he led Women’s Health, Metabolics, and International Business. With over 15 years at Abbott, he held diverse roles, including Head of Sales for Medical Nutrition. Ranganathan’s career spans several reputable organizations, including Baxter, Novo Nordisk, and Torrent Pharma. He holds a bachelor’s degree in Physics and Mathematics from Bangalore University and a Postgraduate Diploma in Marketing from St. Joseph College of Business Administration, Bangalore.
Amit Bakshi, Chairman and Managing Director of Eris Lifesciences, expressed excitement about the new appointment, stating, “Murari’s extensive experience and expertise in the domain will play a crucial role in bolstering our leadership in the cardiometabolic market. We welcome him to the team and look forward to his success.”